Catherine J. Mackey - Jun 30, 2021 Form 3 Insider Report for Trillium Therapeutics Inc. (TRIL)

Role
Director
Signature
/s/ James Parsons, Attorney-in-Fact
Stock symbol
TRIL
Transactions as of
Jun 30, 2021
Transactions value $
$0
Form type
3
Date filed
7/2/2021, 04:34 PM
Previous filing
May 7, 2021
Next filing
Jul 2, 2021

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney